T
Terns Pharmaceuticals, Inc. (TERN)
NMS – Real Time Price. Currency in USD
52.95
-0.02 (-0.03%)
At close: May 15, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
52.95
-0.02 (-0.03%)
At close: May 15, 2026, 4:00 PM EDT
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1/2 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced metabolic stability and liver distribution that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-801 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
| Name | Position |
|---|---|
| Dr. Jeffrey R. Jasper Ph.D. | SVP & Senior Distinguished Research Fellow |
| Mr. James Kanter | Senior Vice President of CMC |
| Mr. Scott Harris | Chief Development & Operations Officer |
| Ms. Amy L. Burroughs M.B.A. | CEO & Director |
| Ms. Caryn Gordon McDowell J.D. | Chief Legal Officer |
| Ms. Debra Sieminski | Senior Vice President of Medical Affairs |
| Ms. Melita Sun Jung | Chief Business Officer |
| Ms. Robin Andrulevich | Chief People Officer |
| Ms. Theresa Clouser | Vice President of Marketing |
| Ms. Yasameen Qazen Pharm.D. | Senior Vice President of Regulatory Affairs & Quality Assurance |
| Date | Type | Document |
|---|---|---|
| 2026-05-05 | POSASR | d147538dposasr.htm |
| 2026-05-05 | POS AM | d129245dposam.htm |
| 2026-05-05 | 8-K | d70112d8k.htm |
| 2026-04-27 | 8-K | d122087d8k.htm |
| 2026-04-27 | 10-K/A | tern-20251231.htm |
| 2026-04-24 | SC 14D9/A | d42499dsc14d9a.htm |
| 2026-04-07 | SC 14D9 | d128161dsc14d9.htm |
| 2026-03-30 | S-8 | tern-20260330.htm |
| 2026-03-30 | 10-K | tern-20251231.htm |
| 2026-03-26 | SC TO-C | d104703dsctoc.htm |